top of page

Scientific Advisory Board

Imophoron's Scientific Advisory Board (SAB) is comprised of internationally renowned experts in infectious diseases, the vaccine industry and public health.


Professor Imre Berger

Co-founder of Imophororon and Chair of Imophoron’s SAB, Professor of Chemistry and Biochemistry at the University of Bristol, Director of the Max Planck Bristol Centre for Minimal Biology and Director of the Bristol Synthetic Biology Centre BrisSynBio. His career of 25+ years spans synthetic biology, structural biology and biotech. Before joining Bristol, he worked and taught at Massachusetts Institute of Technology (USA), ETH Zurich (Switzerland) and EMBL (France). He publishes prolifically in leading periodicals including Nature and Science.

Helen Brightv2.jpg

Dr Helen Bright

Dr Helen Bright is VP of R&D at Centauri Therapeutics and a biopharmaceutical professional and leader with over 25 years of industry experience. She is a leading expert in infectious diseases, immunology and vaccines and has a proven track record of advancing novel small molecules, biologics and vaccine candidates from discovery to the clinic (Investigational New Drug, Biologics License Applications,  Marketing Authorisation Application submissions)


Paul Edwards MBE

Paul Edwards MBE is currently Managing Partner Global Healthcare at Horton International and Director at OBN (UK) Ltd. He has spent over 30 years in the pharmaceuticals and life sciences sector, working initially with Beecham Pharmaceuticals, before joining Genzyme Corporation, where he headed the company’s UK operations  In 2000, he joined the UK based biosimilars’ organisation, GeneMedix plc as Chief Executive Officer, and successfully led a major funding round taking the company to a dual listing on the London and Singapore Stock Exchanges.

Lisa Ng (5).JPG

Dr Lisa Ng

Dr Lisa Ng is a renowned immunologist and expert on infectious diseases including zika, Covid, hepatitis and influenza. She is currently Executive Director of A*STAR’s Biomedical Research Council (BMRC), and holds a concurrent appointment as Executive Director at A*STAR’s Infectious Diseases Laboratories, where she focuses on the immune responses to arthritic arboviruses that are epidemic ,or highly endemic, in the tropical region.


Dr Adam Finn

Dr Adam Finn is a Professor of Paediatrics at the University of Bristol, Head of the Bristol Children’s Vaccine Centre and Director of the recent Pfizer Vaccine Centre of Excellence. He is Chairman of the WHO European Technical Advisory Group of Experts (ETAGE) on Immunization, since 2011, and a member of the UK Department of Health Joint Committee on Vaccination and Immunisation (JCVI), since 2014. In 2015, he was elected President of the European Society for Paediatric Infectious Diseases (ESPID).


Dr Basam Hallis

Dr Bassam Hallis is Deputy Director of UK Health Security Agency and has over 25 years of experience in scientific research in infectious diseases and vaccines and 20 years in regulated activities including vaccine evaluation, release/stability and clinical trial serology. He has extensive experience in assay development and validation including cell-based and functional assays as well as technology transfer of early-stage and validated tests.

bottom of page